ArticleEMBO molecular medicine2024

CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.

Yao Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.